Diagnosis

Esophageal varices

Dilated submucosal esophageal veins connecting the portal and systemic circulations.

Etiology

Cause [zey]

Pathophysiology [zey]

  1. Normal portal pressure: 5-10 mmHg

  2. The portal venous system has no valves --> resistance at any level between the splanchnic vessels and the heart results in retrograde flow and elevated pressure

  3. Liver Cirrhosis --> portal hypertension --> collaterals connect the systemic circulation to the portal venous system --> congested submucosal venous plexus with tortuous dilated veins in the distal esophagus

  4. Increasing size of varices --> increase in variceal-wall tension --> rupture

  5. Mortality rate from variceal bleeding: 20% when patients are treated in hospital

Causes for cirrhosis in children

  1. Intrahepatic:

    • Cholestatic disease:

      • Biliary atresia

      • Progressive familial intrahepatic cholestasis

      • Primary sclerosis cholangitis

      • Cystic fibrosis-related liver disease

      • Intestinal failure-associated liver disease

    • Hepatocellular disease:

      • Autoimmune hepatititis

      • Chronic hepatitis B

      • Chronic hepatitis C

      • Alpha-antitrypsin deficiency

      • Nonalcoholic fatty liver disease

    • Fibrotic disease:

      • Congenital hepatic fibrosis

      • Caroli disease

  2. Prehepatic:

    • Portal vein occlusion:

      • Portal vein thrombosis

      • Tumor infiltration (hpatoblastoma, HCC, focal nodular hyperplasia)

    • Nodular regenerative hyperplasia:

      • Drug (6-thioguanine, Azathioprine)

      • Turner syndrome

    • Portal venopathy/portal sclerosis:

      • Schistosomiasis

      • HIV

      • Cystic fibrosis

  3. Posthepatic:

    • Hepatic vein occlusion:

      • Budd-Chiari syndrome

      • Inferior vena cava obstruction

      • Cognitive heart failure

      • Veno-occlusive disease

Complications [zey]

Epidemiology

Incidence per 100.000 [wfr][1pu][eta]

Epidemiology chart for Incidence

Approach

Treatment

  1. Volume resuscitation: crystalloid or blood (hemoglobin goal of 7-9 g/dl) [zey]

  2. Medication therapy:

    • Octreotide IV 50 µg/hr

    • Antibiotics IV

    • PPI IV (portal hypertensive gastropathy and/or gastric ulcerations may be present)

    • Terlipressin: 2 mg q4h IV

    • Erythromycin 250 mg IV

    • Beta blockers (nitrates are an alternative)

  3. Endoscopy once the patient is hemodynamically stable:

    • Band ligation

    • Sclerotherapy

  4. Surgical Management:

    • Interventional radiology

      • Portal vein stent placement

      • Transjugular Intrahepatic Portosystemic Shunts (TIPS)

    • Surgical intervention:

      • Portal vein venoplasty

      • Shunt surgery: Meso Rex bypass shunt if extrahepatic portal venous obstruction and preserved liver architecture

      • Portosystemic shunt: Distal splenorenal shunts

      • Liver transplantation

      • Splenectomy

Differential diagnoses

Budd-Chiari syndrome, Chronic pancreatitis, Gastric cancer, Gastroesophageal reflux disease, Gastrointestinal hemorrhage, Heart failure, Hemochromatosis, Hypertensive gastropathy, Mallory-Weiss tear, Portal vein thrombosis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Sarcoidosis, Schistosomiasis, Ulcer disease, Viral hepatitis, Wilson's disease


References

[1] Meseeha M, Attia M. Esophageal Varices. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448078/

[2] Jamal MM, Samarasena JB, Hashemzadeh M, Vega KJ. Declining hospitalization rate of esophageal variceal bleeding in the United States. Clin Gastroenterol Hepatol. 2008 Jun;6(6):689-95; quiz 605.

[3] Solanki S, Haq KF, Chakinala RC, Khan Z, Aronow WS, Ali Khan M, Siddiqui MT, Haq KS, Frager S, Alimirah M, Nabors C, Samson DJ, Lebovics E, Wolf DC. Inpatient burden of esophageal varices in the United States: analysis of trends in demographics, cost of care, and outcomes. Ann Transl Med. 2019 Sep;7(18):480.

[4] Rattanamongkolgul S, Wongjitrat C, Puapankitcharoen P. Prevalence of cirrhosis registered in Nakhon Nayok, Thailand. J Med Assoc Thai. 2010 Feb;93 Suppl 2:S87-91.

[5] Sarangapani A, Shanmugam C, Kalyanasundaram M, Rangachari B, Thangavelu P, Subbarayan JK. Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol. 2010 Jan-Mar;16(1):38-42.

Scroll to top